Suchergebnisse - "Vallet, Sonia"

PubPharm (135)

11

Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group

enthalten in: Cancers | 2022

von Leisch, M. | Pfeilstöcker, M. | Stauder, R. | +20

12

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1 : outcome, safety, and risk factors for relapse in a population-based study

enthalten in: Therapeutic advances in medical oncology | 2022

von Dieckmann, K. | Pokrivcak, T. | Geczi, L. | +34

13

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1 : outcome, safety, and risk factors for relapse in a population-based study

enthalten in: Therapeutic advances in medical oncology | March 31, 2022

von Dieckmann, K. | Pokrivcak, T. | Geczi, L. | +34

14

JunB is a key regulator of multiple myeloma bone marrow angiogenesis

enthalten in: Leukemia | 2021

von Fan, F. | Malvestiti, S. | Vallet, S. | +19

ErratumIn: Leukemia. 2021 Sep 6;:. - PMID 34489554

15

Publisher Correction : JunB is a key regulator of multiple myeloma bone marrow angiogenesis

enthalten in: Leukemia | 2021

von Fan, F. | Malvestiti, S. | Vallet, S. | +19

ErratumFor: Leukemia. 2021 Dec;35(12):3509-3525. - PMID 34007044

16

Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma

enthalten in: Cancers | 2021

von Pozzi, S. | Bari, A. | Pecherstorfer, M. | +1

17

Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients

enthalten in: Cancers | 2021

von Singer, J. | Le, N. | Mattes, D. | +9

18

Effect of cachexia on bone turnover in cancer patients : a case-control study

enthalten in: BMC cancer | 2021

von Zwickl, H. | Zwickl-Traxler, E. | Haushofer, A. | +7

19

Effect of cachexia on bone turnover in cancer patients: a case-control study

enthalten in: BMC cancer | 2021

von Zwickl, H. | Zwickl-Traxler, E. | Haushofer, A. | +7

20

Emerging protein kinase inhibitors for the treatment of multiple myeloma

enthalten in: Expert opinion on emerging drugs | 2019

von Lind, J. | Czernilofsky, F. | Vallet, S. | +1